RECENT NEWS

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering for pathology and radiology using Clinisys ICE.

Life sciences firm Eppendorf has announced the commercial launch of the Eppendorf Research 3 neo range of pipettes, designed to deliver accurate and precise results for accelerated volume selection, and optimised ergonomics.

Diagnostic technology firm Randox Laboratories has announced plans to expand its US site in Jefferson County, West Virginia, from a 48-person sales and distribution operation into a full-scale production laboratory, further increasing the company’s 4.1 billion annually manufactured tests.

Newly published data show that nearly 1 in 5 children starting primary school are not fully protected against several serious diseases, prompting the UK Health Security Agency (UKHSA) and NHS England to call for parents and healthcare workers to catch up on missed vaccinations.

Cherwell (an AnalytiChem company) has announced the retirement of Andy Whittard, Managing Director, and the appointment of Stuart Hall, Cherwell’s current Director of Finance, as his successor.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa), a new kind of oral antibiotic pill to treat uncomplicated urinary tract infections (UTIs) in females.

Cancer patients will benefit from the potential for faster diagnosis and better access to specialist opinions, following the go-live of a digital pathology solution across five NHS sites in Devon and Cornwall.

Evident has announced a definitive agreement to acquire Pramana, a leading manufacturer of digital pathology solutions.

A new programme to evaluate how wastewater monitoring could be used to detect a wider range of dangerous pathogens has been launched by the UK Health Security Agency (UKHSA).

Antibiotic susceptibility testing (AST) technology firm Avails Medical has announced that it has signed its first US commercial customer, a world renowned academic medical centre and flagship hospital for a six-hospital system, for the company's eQUANT system.

Tempus AI, a technology company leading the adoption of AI to advance precision medicine, has announced the acquisition of Paige, an AI company specialising in digital pathology.

While it has long been known that gut microbiota plays a role in the development of colorectal cancer, translating these findings into clinical practice has proven challenging. This is because different strains of the same bacterial species can have opposite effects, with some promoting the disease and others having no effect.

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to find subtle tissue changes that allow the cancer to be detected long before it becomes visible to the human eye.

Salmonella Dublin, a type of bacteria that primarily infects cattle but some strains also can adapt to infect humans, is increasingly becoming resistant to antibiotics, making it a growing public health threat, according to the US Centers for Disease Control and Prevention.

Scientists at the Icahn School of Medicine at Mount Sinai have developed a powerful new computational tool that could transform how cancer tissues are analysed and help pave the way for more personalised treatments.

More than 100,000 people in England have now been tested for hepatitis C through the NHS’s confidential home testing service, in a major milestone towards eliminating the virus as a public health threat.

A joint statement has been signed by over 40 UK health funders and charities, to improve understanding of disease and develop better health interventions.

A blood test showing how white blood cells interact with milk proteins could transform the diagnosis and management of cow’s milk allergy in young children.

The UK Government has hailed the success of Community Diagnostic Centres (CDCs), with 100 sites now operational, delivering over 7.2 million tests and scans in the last year.

The latest UK Health Security Agency (UKHSA) data show an increase in travel-associated chikungunya cases in England. A total of 73 cases were reported between January and June 2025.